|
Reference (first author) | Type of cancer | No. of cases | Group | Approach | AAA rupture rate (period) | Interval between AA repair and cancer treatment | Delay in cancer treatment | Cancer outcome | Graft complication rate | % mortality rate (mode) |
|
| CRC | 83 (of 435 AAA pts over 8 yrs) | One: 44pts | CRC treated first. AAA average size 3.8 cm | 1/44 ruptured (7yrs later) 1/44 died of sepsis following repair of AAA (1 yr later) | | 4 days | 13% recurrence | | 4.5% (30 d) |
Baxter et al. [11] | | | Two: 20pts | CRC treated first. AAA average size 5.4 cm | 2/20 (10%) had rAAA postoperatively. 1 died | | 8 days | 33% recurrence | | 10% (30 d) |
| | | Three: 12pts | AAA and CRC treated simultaneously. AAA average size 6.4 cm | 0% | | 15 days | 17% recurrence | | 14% (30 d) |
| | | Four: 7pts | AAA treated first. AAA average size 6 cm | 0% | | 122 days | 9% recurrence | | 8% (30 d) |
|
| Different types (urinary tract, GI, and lung) | 25 | One: 11 | EVAR performed first. AAA average size 5.9 cm | | 6.5 days (average) | | | 2/11 graft occlusion—0/11 infection | 0% (periop) |
Porcellini et al. [27] | | | Two: 7 | Open surgery performed first. AAA average size 6.8 cm | 0 | 34 days | | 3 died of mets (11, 15, and 39 mo) | 1/14 graft infection | 3/14 died after AAA repair |
| | | Three: 6 | One-stage operation | 0 | 0 | | 1 died of mets (15 mo) | | 0% |
| | | Four: 1 | Cancer first | 1 | 82 d | | alive (55 mo) | 0 | 0% |
|
| CRC | 7 | Open: 5 | AAA and CRC treated simultaneously. AAA average size? | 0 | | NS | NS | 0% | |
Herald et al. [28] | | | EVAR: 1 | AAA and CRC treated simultaneously. AAA average size NS | 0 | 0 | NS | Alive (12 months) | 0% | |
| | | EVAR: 1 | AAA before the CRC. AAA average size NS | 0 | 14 | NS | Alive (6 months) | 0% | |
|
Chai et al. [29] | CRC | 2 | | EVAR followed by CRC resection | 0 | 7 | NS | Alive (12 months) | 100% (graft occlusion). Case report type | |
|
Sheen et al. [30] | Pancreas | 1 | | EVAR followed by pancreatectomy | 0 | 9 | NS | Alive (1 month) | 0% | |
|
| Renal | 27 | 11 | One stage | 0 | 0 | | 80% survival | 0 (57months) | |
Hafez et al. [31] | | | 13 | AAA first | 0 | ? | | 35% survival | 0 (57months) | |
| | | 3 | Renal malignancy first | 0 | ? | | 80% survival | 0 (57months) | |
| | | | different grouping | | | | | | |
|
Matsumoto et al. [10, 32] | Gastric and colorectal cancer | 25 (out of 186 AAA repairs) - high risk pts only included | Group 1: 14 | One-stage operation | 0 | | NA | 2 died of renal failure (10 mo) or mets (2yrs) | NA | 0 (Periop) |
| | | Group 2: 11 | Two-stage operation | 0 | | NA | 1 died of Mi (3 mo) | NA | 0 (Periop) |
|
| CRC | 108 | Group 1: 46 | CRC treated first. AAA second: group A: 35 open/group B: 11 EVAR | | A: 42 d/B: 35 | | | 2/11 (Group B) had sigmoid ischaemia | |
Lin et al. [33] | | | Group 2: 38 | AAA first: Group C: 26 open/ Group D: 12 EVAR | | | C: 115/ D: 12 | Significant periop morbidity/mortality in Group C | | |
| | | Group 3: 8 | Combined | | | | | | |
|
| All (mostly CRC) | 7 (127 AAAs) | Group 1: 3 | One stage | | | | | 0% | |
Suffat et al. [34] | | | Group 2: 1 | Two stage (?) | | | | | 0% | |
| | | Group 3: 3 | EVAR | | | Few days | | 0% | |
|
| gastric | 6 (222 AAAs) | Group 1: 3 | CRC first (advanced cancer) | | | | 71% alive at 4 yrs | | |
Komori et al. [35] | | | Grorp 2: 1 | AAA first (>6 cm) | | | | | | |
| | | Group 3: 2 | One stage | | | | | | |
|
| CRC | 13 | Group 1: 10 | CRC first; Open AAA (3) or EVAR (7) second | 0 | | | | 0 | |
Shalhoub et al. [36] | | | Group 2: 2 | AAA first (diameter 7&8 cm) | 0 | | | | 0 | |
| | | Group 3: 1 | | 0 | | | | 0 | |
|
Oshodi et al. [8] | All | 56 (676) | | One-stage open surgery | 3 deaths/ 7 early reoperation | 0 | | | 0 | 0 (Periop) |
|
Galt et al. [37] | renal | 10 | | One stage | 0 | 0 | NS | 1 died from mets | 0 | |
|
Veraldi et al. [38] | CRC | 14 | Group 1: 9 | One stage | 0 | 0 | | NA | 0 (up to 5yrs) | 0 (Periop) |
| | | Group 2: 7 | Two stage | 0 | 31 d | | NA | | |
|